Abstract
Chronic kidney disease has become a global public health problem with serious social and economic effects from premature morbidity and deaths. Kidney stone formers are at increased risk for chronic kidney disease (CKD)—both early and advanced stages—with the stone acting either as the initiating or a contributing factor. Recent data indicates that prevalence and incidence of kidney stone are increasing worldwide. Individuals with kidney stones should be screened for the presence of underlying CKD. This chapter reviews the burden of CKD, the risk of kidney stone formation, and the association of CKD with kidney stones and underscores the need for screening and preventive strategies for CKD in individuals with kidney stones.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Alberta kidney disease network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423–9.
Remuzzi G. A research program for COMGAN. ISN News. July 2001:1–6.
Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A. US renal data system 2010 annual data report. Am J Kidney Dis. 2011;57(1 Suppl 1):A8, e1–526.
Jafar TH. The growing burden of chronic kidney disease in Pakistan. N Engl J Med. 2006;354:995–7.
Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354:997–9.
Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–80.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69.
Alsuwaida AO, Farag YM, Al Sayyari AA, Alhejaili F, AlHarbi A, Houswi A. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (Seek Saudi Investigators). Saudi J Kidney Dis Transpl. 2010;21:1066–72.
Husseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of kidney disease in Iran: a large population based study. BMC Public Health. 2009;9:44.
Ingsathit A, Thakkiinstian A, Chaipraset A, Sangthawan P, Sangthawan P, Gojaseni P, et al. Prevalence and risk factors for chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25:1567–75.
Rule A, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011;6:2069–75.
Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–93.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.
Johnson CN, Wilson DM, O’Fallen WM, Malek RS, Kurland RT. Renal stone epidemiology: a 25 years study in Rochester Minnesota. Kidney Int. 1979;16:624–31.
Lieske JC, de la Pena Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KI, et al. Renal stone epidemiology in Rochester, Minnesota. An update. Kidney Int. 2006;69:760–4.
Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–9.
Robertson WG. Epidemiology of urinary stone disease. Urol Res. 1990;18 Suppl 1:S3–8.
Johri N, Jaeger P, Robertson W, Choong S, Unwin R. Renal stone disease. Medicine. 2011;39(7):371–7.
Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13 Suppl 3:S45–50.
Romero V, Akpinar H, Assimos DG. Kidney stone: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.
Yoshida O, Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int. 1990;45(2):104–11.
Yanagaw M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue V, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997;4(6):537–40.
Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanism, and prevention. Am J Kidney Dis. 2004;44:799–805.
Stankus N, Hammes M, Gillen D, Worcester E. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res. 2007;35(2):83–7. Epub 2007 Feb 20.
Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005;67(2):685–90.
Gooneratne IK, Ranaweera AK, Liyanarachchi NP, Gunawardane N, Lanerolle RD. Epidemiology of chronic kidney disease in Sri Lankan population. Int J Diabetes Dev Ctries. 2008;28:60–4.
Abboud OL, Osman EM, Musa AR. The etiology of chronic renal failure in adult Sudanese patients. Ann Trop Med Parasitol. 1989;83:411–4.
Sitiprija V. Nephrology in south east Asia: fact and concept. Kidney Int. 2003;63(S83):s128–30.
Afshar R, Sanavi S, Salimi J. Epidemiology of chronic renal failure in Iran: a four year single center experience. Saudi J Kidney Dis Transplant. 2007;18:191–4.
Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris). 2005;39:209–31.
Safaraninejad MR. Adult urolithiasis in a population bases study in Iran: prevalence, incidence, and associated risk factors. Urol Res. 2007;35:73–82.
Rizvi SAH, Manzoor K. Causes of chronic renal failure in Pakistan: a single large center experience. Saudi J Kidney Dis Transplant. 2002;13:376–9.
Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol. 2003;14:1082–95.
Scheinman SJ. Nephrolithiasis. Semin Nephrol. 1999;19:381–8.
Robertson WG, Peacock M, Marshall RW, Speed R, Nordin BE. Seasonal variations in the composition of urine in relation to calcium stone-formation. Clin Sci Mol Med. 1975;49:597–602.
Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol. 2005;16:729–45.
Parry ES, Lister IS. Sunlight and hypercalciuria. Lancet. 1975;1:1063–5.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–73.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.
Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999;81 suppl 1:26–30.
Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011;79(11):1178–85.
Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. N Eng J Med. 1968;278:1313–8.
Ljunghall S, Danielson BG, Fellström B, Holmgren K, Johansson G. Family history of renal stones in recurrent stone patients. Br J Urol. 1985;57(4):370–4.
Pishchalnikov YA, McAteer JA, Williams Jr JC, et al. Why stones break better at slow shockwave rates than at fast rates: in vitro study with a research electrohydraulic lithotripter. J Endourol. 2006;20(8):537–41.
Connors BA, Evan AP, Blomgren PM, et al. Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Int. 2009;104(7):1004–8.
Bander SJ, Buerkert JE, Martin D, Klahr S. Long-term effects of 24-h unilateral ureteral obstruction on renal function in the rat. Kidney Int. 1985;28:614.
Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.
Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128(7):534–40.
Siener R, Ebert D, Nicolay C, et al. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int. 2003;63(3):1037–43.
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.
Fink HA, Akornor JW, Garimella PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009;56(1):72–80.
Hesse AT, Tiselius H-G, Siener R, Hoppe B, editors. Urinary stones, diagnosis, treatment and prevention of recurrence. 3rd ed. Basel: S Karger AG; 2009.
Stitchantrakul W, Sopassathit W, Prapaipanich S, et al. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake. Southeast Asian J Trop Med Public Health. 2004;35(4):1028–33.
von Unruh GE, Voss S, Sauerbruch T, et al. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004;15(6):1567–73.
Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980;128:439–50.
Sarig S. The hyperuricosuric calcium oxalate stone former. Miner Electrolyte Metab. 1987;13(4):251–6.
Ettinger B. Hyperuricosuric calcium stone disease. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, editors. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven; 1996. p. 851–8.
Constanzo LS, Windhager EE. Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol. 1978;235(5):F492–506.
Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.
Jafar TH, Paul C, Stark PC, Schmid CH, Landa M, Maschio G, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Ali, A., Khan, Q., Jafar, T.H. (2012). Kidney Stones and Chronic Kidney Disease. In: Talati, J., Tiselius, HG., Albala, D., YE, Z. (eds) Urolithiasis. Springer, London. https://doi.org/10.1007/978-1-4471-4387-1_74
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4387-1_74
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4383-3
Online ISBN: 978-1-4471-4387-1
eBook Packages: MedicineMedicine (R0)